Gene therapy marks a new era of medicine, bringing with it a new paradigm for R&D and hope for patients with previously incurable genetic disorders. To deliver on the promise of gene therapy, companies need a modern informatics platform that can handle the complexity of gene therapy R&D. Benchling is that platform for hundreds of innovative gene therapy companies including uniQure, Editas Medicine, and Beam Therapeutics. It helps scientists be more productive, makes it easier to get insights from the data, and helps teams collaborate across R&D.
The new speed of science, made possible by Benchling.